Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


University of Oklahoma Health Sciences Center

Latest From University of Oklahoma Health Sciences Center

Mobile Health Promises To Uproot, Uplift Medical Devices

Medical Device Strategy

AF Ablation: Finding the Right Mix

For a number of reasons, 2009 was a big year for the atrial fibrillation ablation market. Early in the year, Biosense Webster received FDA approval for its radiofrequency ablation catheter, the first such device to launch in the US with a specific AF indication. That approval was much more than just a landmark event for J&J; it changed the landscape of the AF industry, reinvigorating interest in the funding and development of new catheter-based technologies--a trend that has extended through to 2010 and will likely continue in the years ahead.

Medical Device

Recent Financings of Private Companies (11/2007)

Each month, Start-Up presents a comprehensive review of young, private life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.

EuroPACE Highlights: AF Cath Ablation Interest Heats Up

Catheter ablation dominated the biannual EuroPACE meeting held in Lisbon at the end of June. In addition to the range of manual catheter ablation systems, remote catheter navigation and mapping also attracted large audiences.

Medical Device
See All

Company Information

  • Industry
  • Academic and Research Institutions